Modification of exhaled air nitric oxide in patients with asthma – cortisone monotherapy or dual inhalation therapy?

Building porphyrin-based MOFs on MXenes for ppb-level NO sensing

“…As a signicant biological signaling molecule, 1,2 fractional exhaled nitric oxide (FeNO, below 100 ppb) reects the eosinophilic inammation of the airways, which could evaluate respiratory diseases, such as asthma and chronic cough, and predict the treatment responses. [3][4][5] Moreover, some studies have shown that FeNO level is a predictor of COVID-19 disease severity. [6][7][8][9] Obviously, the detection of ppb-level nitric oxide (NO) has its unique credit in the clinical diagnosis of respiratory diseases.…”